Cite
HARVARD Citation
Hellemans, R. et al. (n.d.). Daclizumab Versus Rabbit Antithymocyte Globulin in High‐Risk Renal Transplants: Five‐Year Follow‐up of a Randomized Study. American journal of transplantation. 15 (7), pp. 1923-1932. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hellemans, R. et al. (n.d.). Daclizumab Versus Rabbit Antithymocyte Globulin in High‐Risk Renal Transplants: Five‐Year Follow‐up of a Randomized Study. American journal of transplantation. 15 (7), pp. 1923-1932. [Online].